- Intensive Care Unit Cognitive Disorders
- Cardiac Imaging and Diagnostics
- Mechanical Circulatory Support Devices
- Coronary Interventions and Diagnostics
- Long-Term Effects of COVID-19
- Vascular Malformations and Hemangiomas
- Vascular Tumors and Angiosarcomas
- Family and Patient Care in Intensive Care Units
- Cardiac tumors and thrombi
- Cerebrovascular and Carotid Artery Diseases
Heart and Diabetes Center North Rhine-Westphalia
2023-2025
Ruhr University Bochum
2023-2025
Bielefeld University
2024
Objectives: A systematic characterization of the long-term sequelae after severest form COVID-19 requiring ECMO-therapy is lacking. Here, we present 2-year follow-up data ECMO survivors, and analyze cardiopulmonary, neurocognitive, psychological, functional status, plus health-related quality life (HRQL). Methods: From 04/2020 to 09/2021, 60 COVID patients were supported with ECMO. Survival discharge was 40.0% ( n = 24), 6-month survival 33.3% 20). Follow-ups performed via phone mail using...
Extracorporeal membrane oxygenation (ECMO) is increasingly used in COVID-19-related pulmonary failure and the number of patients recovering from COVID-19 growing. Here, we assess survival recovery 6 months after ECMO for COVID-19. From April 2020 to September 2021, n = 60 (60.5 [51.0-65.0] years, 23.3% female) were treated with venovenous/venoarterial 41.7% weaned off ECMO, survival-to-discharge was 40.0% (n 24). Age (63.0 [60.0-66.8] vs. 55.0 [43.8-60.0] p < 0.001), vasoactive support...
Primary cardiac tumours are rare, accounting for only 0.002-0.03% at autopsy. Cardiac haemangiomas benign vascular and constitute 0.28% of all primary tumours. Cavernous haemangiomas, capillary arteriovenous three distinct types. often misdiagnosed as myxomas must be differentiated from malignant angiosarcomas.
Coronary artery disease is a global cause of morbidity and mortality, often managed by coronary bypass grafting (CABG). This study addresses critical decision-making dilemma in CABG procedures for patients with severe asymptomatic carotid stenosis, comparing off-pump on-pump techniques.
Background: Little is known on the impact of COVID-19-associated intensive care medical therapy including extracorporeal life support/membrane oxygenation (ECMO) long-term well-being survivors. The aim this study to comprehensively characterize recovery six months after ECMO treatment for pulmonary failure.